FDA announces that “GLP-1 receptor agonists” used to treat obesity and diabetes, including Victoza, may increase the risk of vision loss

[Washington – Keiichi Nakane] The U.S. Food and Drug Administration (FDA) announced that “GLP-1 receptor agonists,” used to treat obesity…